I agree that this site is using cookies. You can find further informations here.
X
Hendrickson, Barbara
83  results:
Search for persons X
?
1

Fibrosing Mediastinitis Caused by Histoplasmosis in an Adol..:

Ganigara, Madhusudan ; Flores, John J. ; Slivnick, Jeremy...
JACC: Case Reports.  29 (2024)  2 - p. 102161 , 2024
Link: https://doi.org/10.1016/..
 
?
2

How Aggregate Safety Assessment Planning Supports Investiga..:

Hendrickson, Barbara A. ; McShea, Cynthia ; Ball, Greg.
Therapeutic Innovation & Regulatory Science.  58 (2024)  4 - p. 579-590 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Aggregate IND Safety Reporting for Smaller Companies and Pr..:

Ball, Greg ; Li, Mengchun ; Buchanan, Jim...
Therapeutic Innovation & Regulatory Science.  58 (2024)  2 - p. 368-379 , 2024
Link: https://doi.org/10.1007/..
 
?
4

Safety of upadacitinib in moderate-to-severe atopic dermati..:

Guttman-Yassky, Emma ; Thyssen, Jacob P. ; Silverberg, Jonathan I....
Journal of Allergy and Clinical Immunology.  151 (2023)  1 - p. 172-181 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Assessing adverse events in clinical trials during the era ..:

Buchanan, James ; Li, Mengchun ; Hendrickson, Barbara..
Journal of Biopharmaceutical Statistics.  33 (2023)  4 - p. 466-475 , 2023
Link: https://doi.org/10.1080/..
 
?
6

Value and Implementation of the Aggregate Safety Assessment..:

Hendrickson, Barbara A. ; Agarwal, Anupam ; Bennett, Dimitri...
Pharmaceutical Medicine.  , 2023
Link: https://doi.org/10.1007/..
 
?
7

Evaluation of response to 13-valent conjugated pneumococcal..:

Winthrop, Kevin ; Vargas, Juan Ignacio ; Drescher, Edit...
RMD Open.  8 (2022)  1 - p. e002110 , 2022
Link: https://doi.org/10.1136/..
 
?
8

Aggregate Safety Assessment Planning for the Drug Developme..:

Hendrickson, Barbara A. ; Wang, William ; Ball, Greg...
Therapeutic Innovation & Regulatory Science.  , 2021
Link: https://doi.org/10.1007/..
 
?
9

Using the Bayesian detection of potential risk using infere..:

Waterhouse, Brian ; Hartford, Alan ; Mukhopadhyay, Saurabh..
Pharmaceutical Statistics.  21 (2021)  2 - p. 372-385 , 2021
Link: https://doi.org/10.1002/..
 
?
10

Interdisciplinary Safety Evaluation for Learning and Decisi..:

Ball, Greg ; Hendrickson, Barbara A. ; Freedman, Amy L....
Therapeutic Innovation & Regulatory Science.  , 2021
Link: https://doi.org/10.1007/..
 
?
11

Safety and efficacy of upadacitinib in combination with top..:

Reich, Kristian ; Teixeira, Henrique D ; de Bruin-Weller, Marjolein...
The Lancet.  397 (2021)  10290 - p. 2169-2181 , 2021
Link: https://doi.org/10.1016/..
 
?
12

Safety profile of upadacitinib in rheumatoid arthritis: int..:

Cohen, Stanley B ; van Vollenhoven, Ronald F ; Winthrop, Kevin L...
Annals of the Rheumatic Diseases.  80 (2020)  3 - p. 304-311 , 2020
Link: https://doi.org/10.1136/..
 
?
13

P209 Safety profile of upadacitinib in rheumatoid arthritis..:

Burmester, Gerd Rüdiger ; Enejosa, Jeffrey V ; Hendrickson, Barbara...
Rheumatology.  59 (2020)  Supplement_2 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
14

Global Regulatory Landscape for Aggregate Safety Assessment..:

Ball, Greg ; Kurek, Raffael ; Hendrickson, Barbara A....
Therapeutic Innovation & Regulatory Science.  54 (2020)  2 - p. 447-461 , 2020
Link: https://doi.org/10.1007/..
 
?
15

Monitoring Drug Safety in Rheumatoid Arthritis Prevention T..:

Neagu, Martha R. ; Weinreich, Michael A. ; Doan, Thao T..
Clinical Therapeutics.  41 (2019)  7 - p. 1366-1375 , 2019
Link: https://doi.org/10.1016/..
 
1-15